To examine whether this was due to the IM-induced production of FGF2 by GIST cells, we introduced the neutralizing anti-FGF2 Abs into the culture of the IM-treated GIST and observed the significant decrease in VEGF-A (Figure 2A—left panel). The gene discussed is FGF2; the disease is gastrointestinal stromal tumor.